Search for: "Boehringer Ingelheim Corporation"
Results 1 - 20
of 47
Sort by Relevance
|
Sort by Date
21 Apr 2021, 4:00 am
It is well established in trademark jurisprudence that the owner of a mark is not legally responsible for torts allegedly perpetrated by its user: Batten v Boehringer Ingelheim (Canada) Ltd., 2017 ONSC 53, at para. 153. [read post]
30 Jan 2020, 5:29 am
The Zantac litigation effort involves several international drug companies, including Boehringer Ingelheim Pharmaceuticals (based in Connecticut); Boehringer Ingelheim Corporation (German parent company); Sanofi US Services, Inc. [read post]
30 Jan 2020, 5:29 am
The Zantac litigation effort involves several international drug companies, including Boehringer Ingelheim Pharmaceuticals (based in Connecticut); Boehringer Ingelheim Corporation (German parent company); Sanofi US Services, Inc. [read post]
1 Aug 2019, 8:30 am
Boehringer Ingelheim Corp., et al., a $150 million settlement with GlaxoSmithKline PLC, and a $190 million settlement with Aventis Pharmaceuticals, Inc. [read post]
19 Oct 2018, 2:17 am
Our largest and most innovative pharmaceutical company, Boehringer Ingelheim, has a German "mother“ if I may call it that, which accordingly means that its patent division is in Germany as well. [read post]
4 Sep 2018, 7:00 am
Boehringer Ingelheim Pharmaceuticals, Inc., 892 F.3d 1264 (D.C. [read post]
4 Sep 2018, 7:00 am
Boehringer Ingelheim Pharmaceuticals, Inc., 892 F.3d 1264 (D.C. [read post]
9 Jul 2018, 6:30 pm
Boehringer Ingelheim Pharmaceuticals, Inc., 2018 WL 3028972 (CADC June 19, 2018). [read post]
9 Jul 2018, 6:30 pm
Boehringer Ingelheim Pharmaceuticals, Inc., 2018 WL 3028972 (CADC June 19, 2018). [read post]
30 Dec 2016, 2:58 pm
Permission to appeal in patent cases - farewell to the Pozzoli approachGuest Kat Eibhlin Vardy recaps the case Teva UK Ltd v Boehringer Ingelheim Pharma GmbH & Co KG, [2016] EWCA Civ 1296. [read post]
20 Mar 2015, 8:00 am
Another blood thinning drug, Pradaxa, was manufactured by Boehringer Ingelheim Pharmaceuticals, which produced the blood-thinning drug. [read post]
9 Mar 2015, 2:38 pm
Litigation and Government Investigations at Boehringer Ingelheim Pharmaceuticals where she oversaw all U.S. litigation and government investigations. [read post]
4 Mar 2015, 1:32 pm
Last week, MBBP’s Scott Bleier attended a panel discussion hosted by the Johnson & Johnson Boston Innovation Center, which featured three corporate venture capitalists from Sanofi-Genzyme Bioventures, Boehringer Ingelheim Venture USA Inc. and Johnson & Johnson Development Corp. [read post]
21 Jan 2015, 3:02 pm
But as we’ve blogged, thousands of patients on Pradaxa, which was the first of the three to be approved by the FDA, have been harmed by uncontrolled bleeding, and its manufacturer, Boehringer Ingelheim, has been fined for covering up adverse outcomes in its research for the drug. [read post]
23 Sep 2014, 4:38 am
BootsDeckers Outdoor Corporation v J.C. [read post]
19 Sep 2014, 5:50 pm
Michael Kompter (Senior Patent Counsel, IP Awareness and Enforcement, Boehringer Ingelheim, Germany) considered the issue of privilege from the standpoint of a civil law jurisdiction, as well as providing an in-house counsel’s perspective. [read post]
8 Jun 2014, 2:52 pm
Boehringer Ingelheim does not admit guilt nor accept that Pradaxa is unsafe. [read post]
3 Apr 2014, 5:00 am
and because sales reps are a mobile workforce without benefit of offices within corporate headquarters. [read post]
25 Jan 2014, 9:43 am
In re Petition of Boehringer Ingelheim Pharmaceuticals, Inc., No. 13-3898 (7th Cir. [read post]
31 Jan 2013, 12:57 pm
The plaintiffs brought a product liability claim against Boehringer Ingelheim Pharmaceuticals, Inc. [read post]
